Pharmaceutical NEWS
Text size:
T
T
T
Report Sees Sharp Rise in Pharma RFID
U.K. consultancy IDTechEx expects as many as 10 drug companies will commit to RFID trials in the coming year.
By Beth Bacheldor
May 8, 2006—The health-care market has been advocating the use of RFID technology for several years. A recently released study indicates the level of advocacy is about to get a lot healthier.
The report, "RFID in Healthcare 2006-2016," published by IDTechEx, indicates the worldwide market for RFID tags and systems in health care will rise sharply from $90 million this year to $2.1 billion by 2016. The report culled its findings from 72 case studies, supplier profiles, technology analysis and several industry forecasts.
Much of the growth will be spurred by the item-level tagging of drugs, says Peter Harrop, chairman of IDTechEx, a consultancy headquartered in Cambridge, England, that specializes in RFID, smart packaging and printed electronics. Pfizer and GlaxoSmithKline both launched RFID pilots to tag individual containers of prescription drugs, and the U.S. Food and Drug Administration (FDA) is actively studying RFID to combat drug counterfeiting. The agency is expected to release a report later this month outlining recommendations on how it should move forward to make the pharmaceutical supply chain more secure (see FDA to Update Its RFID Vision).
Harrop says he and other analysts expect up to 10 drug companies will commit to RFID trials next year. "Suppliers believe the FDA will come down with a big foot," he says. "I was actually talking with a supplier involved in one of the current RFID trials that thinks the FDA—if not by the end of this year, then certainly next year—will mandate RFID. Rightly or wrongly, the industry believes the FDA will lay down the law."
Real-time locating systems (RTLS) will be the second-largest contributor to RFID's growth in the health-care industry, according to the report. "We didn't expect to show that health care was increasing its share in the RFID market, in money terms, because everyone is talking about tagging cases and pallets in the retail markets," says Harrop. "But RFID has been quietly rising in health care because a lot of these applications have to do with the saving of lives and safety and security. And the health-care industry is often happy to invest in that kind of technology, even if there might be really long paybacks."
more Pharmaceutical articles
May 8, 2006—The health-care market has been advocating the use of RFID technology for several years. A recently released study indicates the level of advocacy is about to get a lot healthier.
The report, "RFID in Healthcare 2006-2016," published by IDTechEx, indicates the worldwide market for RFID tags and systems in health care will rise sharply from $90 million this year to $2.1 billion by 2016. The report culled its findings from 72 case studies, supplier profiles, technology analysis and several industry forecasts.
|
| Peter Harrop |
Harrop says he and other analysts expect up to 10 drug companies will commit to RFID trials next year. "Suppliers believe the FDA will come down with a big foot," he says. "I was actually talking with a supplier involved in one of the current RFID trials that thinks the FDA—if not by the end of this year, then certainly next year—will mandate RFID. Rightly or wrongly, the industry believes the FDA will lay down the law."
Real-time locating systems (RTLS) will be the second-largest contributor to RFID's growth in the health-care industry, according to the report. "We didn't expect to show that health care was increasing its share in the RFID market, in money terms, because everyone is talking about tagging cases and pallets in the retail markets," says Harrop. "But RFID has been quietly rising in health care because a lot of these applications have to do with the saving of lives and safety and security. And the health-care industry is often happy to invest in that kind of technology, even if there might be really long paybacks."
